Chief Financial Officer
Kedar Upadhye is the Chief Financial Officer (CFO) of Biocon Biologics. He is responsible for driving strong, sustainable, and profitable growth of the company, accelerating its fundraising initiatives, ensuring fiscal prudence and being a strategic partner and enabler as Biocon Biologics rapidly expands its global footprint.
Kedar joined Biocon Biologics in October 2023. He brings with him over 23 years of experience in senior global leadership roles spanning Corporate Finance, Strategy, Accounting, FP&A, Business Finance, Governance and Investor Relations at leading Pharma, Energy and FMCG players such as Cipla, Dr. Reddy’s, PepsiCo, and Thermax.
He joins Biocon Biologics from ReNew Energy Global Plc, a NASDAQ-listed decarbonization and renewable energy company, where he was the CFO.
Prior to ReNew, Kedar was the Global CFO & Head of IT at Cipla. There he was instrumental in setting up a strong global finance footprint with a focus on capital allocation, strategic partnership with the business, governance, and risk management in addition to driving the organization towards the next level of growth and delivering a superior return profile.
He has a proven track record of overseeing value creation, strengthening investor relations and acting as an enabler of business.
He holds an MBA from the Indian Institute of Management (IIM), Bangalore, and is a qualified Company Secretary, as well as a Cost Accountant.